Shandong Sito Bio-technology (300583.SZ): The chemical raw material drug budenide passed the drug GMP compliance inspection.

Shandong Sito Bio-technology (300583.SZ) announced that its holding subsidiary Shandong Succeed Pharmaceutical Co., Ltd. recently received a "Drug GMP Compliance Inspection Notification" issued by the Shandong Provincial Drug Administration, with the inspection scope covering the production workshop and production line for the active pharmaceutical ingredient (API) budesonide: workshop 04, line 02. The chemical API budesonide passed the Drug GMP Compliance Inspection, indicating that the API has met the relevant requirements of the national drug production quality management regulations. This marks that the company can officially produce and sell the above-mentioned API products. This will help the company to maintain stable product quality and continuous production capacity in order to meet the market demand for related drugs.